SCA
MRK icon

Salient Capital Advisors’s Merck MRK Stock Holding History

Salient Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,306
Closed -$1.18M – 143
2017
Q2 		$1.18M Buy
19,306
+15,929
+472% +$970K 0.02% 115
2017
Q1 		$205K Buy
+3,377
New +$205K ﹤0.01% 246
2016
Q4 		– Sell
-4,095
Closed -$244K – 250
2016
Q3 		$244K Buy
+4,095
New +$239K ﹤0.01% 219
2016
Q2 		– Sell
-4,655
Closed -$235K – 260
2016
Q1 		$235K Sell
4,655
-1,992
-30% -$97.6K 0.01% 226
2015
Q4 		$335K Buy
6,647
+1,746
+36% +$88K 0.01% 206
2015
Q3 		$231K Sell
4,901
-4,393
-47% -$233K 0.01% 222
2015
Q2 		$505K Buy
9,294
+3,034
+48% +$170K 0.01% 176
2015
Q1 		$343K Buy
6,260
+691
+12% +$39.1K 0.01% 196
2014
Q4 		$302K Buy
5,569
+225
+4% +$12.5K 0.01% 204
2014
Q3 		$302K Buy
5,344
+168
+3% +$9.43K 0.01% 203
2014
Q2 		$286K Sell
5,176
-15
-0.3% -$818 0.01% 203
2014
Q1 		$281K Buy
5,191
+21
+0.4% +$1.09K 0.01% 194
2013
Q4 		$247K Buy
+5,170
New +$236K 0.01% 189

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salient Capital Advisors's MRK Position: Q3 2017 in Review

Salient Capital Advisors sold out of Merck (MRK) in Q3 2017, closing a stake of 19,306 shares — an estimated $1.18M sold.

Salient Capital Advisors first reported a position in MRK in Q4 2013 and held it in 13 quarters. The position peaked at $1.18M in Q2 2017. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Salient Capital Advisors reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 19,306 Merck shares in Q3 2017, an estimated $1.18M.
  • Salient Capital Advisors first reported a position in Merck in Q4 2013 and held it in 13 quarters.
  • Salient Capital Advisors's Merck position peaked at $1.18M in Q2 2017.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.